Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ENTOMOPHARM ApS
APS
Bankrupt
CVR 32070108
Krakasvej 17, 3400
Hillerød
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2009 · 17 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
ENTOMOPHARM ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2012
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
-2M
2012
Income statement
DKK thousands
Item
2012
Gross profit
446
Staff expenses
-2.307
EBITDA
-1.861
Depreciation & amort.
-102
EBIT
-1.963
Net financials
-215
Profit before tax
Balance sheet
DKK thousands
Item
2012
Total assets
1.609
Equity
-1.862
Long-term debt
3.278
Short-term debt
193
Total debt
3.471
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-417.1%
This company
2012
2012
Equity ratio
-115.7%
This company
38.2%
Market median
Annual reports & filings
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on ENTOMOPHARM ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
-2.178
Tax
24
Net profit
-2.202
-403% vs market
2012
2012
Return on equity
-220243800.0%
This company
18.4%
Market median
-1196977274% vs market
2012
2012
Net profit margin (of gross profit)
-493.6%
This company
2012
2012
Asset turnover (of gross profit)
0.28×
This company
2012
2012
Debt / equity
1.86×
This company
0.62×
Market median
-200% vs market
2012
2012